BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10849442)

  • 1. Do structural deviations between toxins adopting the same fold reflect functional differences?
    Ricciardi A; le Du MH; Khayati M; Dajas F; Boulain JC; Menez A; Ducancel F
    J Biol Chem; 2000 Jun; 275(24):18302-10. PubMed ID: 10849442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of a structural scaffold upon activity transfer: X-ray structure of a three fingers chimeric protein.
    Le Du MH; Ricciardi A; Khayati M; Ménez R; Boulain JC; Ménez A; Ducancel F
    J Mol Biol; 2000 Mar; 296(4):1017-26. PubMed ID: 10686100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theoretical analysis of the structure of the peptide fasciculin and its docking to acetylcholinesterase.
    van den Born HK; Radić Z; Marchot P; Taylor P; Tsigelny I
    Protein Sci; 1995 Apr; 4(4):703-15. PubMed ID: 7613468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mouse acetylcholinesterase by fasciculin: crystal structure of the complex and mutagenesis of fasciculin.
    Marchot P; Bourne Y; Prowse CN; Bougis PE; Taylor P
    Toxicon; 1998 Nov; 36(11):1613-22. PubMed ID: 9792178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic peptides derived from the central loop of fasciculin: structural analysis and evaluation as inhibitors of acetylcholinesterase.
    Falkenstein RJ; Peña C
    Biochim Biophys Acta; 1997 Jun; 1340(1):143-51. PubMed ID: 9217024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of an acetylcholinesterase-fasciculin complex: interaction of a three-fingered toxin from snake venom with its target.
    Harel M; Kleywegt GJ; Ravelli RB; Silman I; Sussman JL
    Structure; 1995 Dec; 3(12):1355-66. PubMed ID: 8747462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and activity of mutants of fasciculin, a peptidic acetylcholinesterase inhibitor from mamba venom.
    Marchot P; Prowse CN; Kanter J; Camp S; Ackermann EJ; Radić Z; Bougis PE; Taylor P
    J Biol Chem; 1997 Feb; 272(6):3502-10. PubMed ID: 9013597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of a green mamba toxin that activates muscarinic acetylcholine receptors, as studied by nuclear magnetic resonance and molecular modeling.
    Ségalas I; Roumestand C; Zinn-Justin S; Gilquin B; Ménez R; Ménez A; Toma F
    Biochemistry; 1995 Jan; 34(4):1248-60. PubMed ID: 7827075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR and restrained molecular dynamics study of the three-dimensional solution structure of toxin FS2, a specific blocker of the L-type calcium channel, isolated from black mamba venom.
    Albrand JP; Blackledge MJ; Pascaud F; Hollecker M; Marion D
    Biochemistry; 1995 May; 34(17):5923-37. PubMed ID: 7727450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1.9-A resolution structure of fasciculin 1, an anti-acetylcholinesterase toxin from green mamba snake venom.
    le Du MH; Marchot P; Bougis PE; Fontecilla-Camps JC
    J Biol Chem; 1992 Nov; 267(31):22122-30. PubMed ID: 1429564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The fasciculin-acetylcholinesterase interaction].
    Marchot P
    J Soc Biol; 1999; 193(6):505-8. PubMed ID: 10783708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three classes of snake neurotoxins by homology modeling and computer simulation graphics.
    Juan HF; Hung CC; Wang KT; Chiou SH
    Biochem Biophys Res Commun; 1999 Apr; 257(2):500-10. PubMed ID: 10198241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasciculins, anticholinesterase toxins from the venom of the green mamba Dendroaspis angusticeps.
    Karlsson E; Mbugua PM; Rodriguez-Ithurralde D
    J Physiol (Paris); 1984; 79(4):232-40. PubMed ID: 6530667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of a chimeric peptide derived from fasciculin that inhibits acetylcholinesterase.
    Falkenstein RJ; Gornalusse GG; Peña C
    J Pept Sci; 2004 Jun; 10(6):342-9. PubMed ID: 15214439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of structure-activity relationship of fasciculin by acetylation of amino groups.
    Cerveñanský C; Engström A; Karlsson E
    Biochim Biophys Acta; 1994 Jan; 1199(1):1-5. PubMed ID: 8280746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholinesterase inhibition by fasciculin: crystal structure of the complex.
    Bourne Y; Taylor P; Marchot P
    Cell; 1995 Nov; 83(3):503-12. PubMed ID: 8521480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II.
    Kryger G; Harel M; Giles K; Toker L; Velan B; Lazar A; Kronman C; Barak D; Ariel N; Shafferman A; Silman I; Sussman JL
    Acta Crystallogr D Biol Crystallogr; 2000 Nov; 56(Pt 11):1385-94. PubMed ID: 11053835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamical properties of fasciculin-2.
    Baker NA; Helms V; McCammon JA
    Proteins; 1999 Sep; 36(4):447-53. PubMed ID: 10450086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-conventional toxins from Elapid venoms.
    Nirthanan S; Gopalakrishnakone P; Gwee MC; Khoo HE; Kini RM
    Toxicon; 2003 Mar; 41(4):397-407. PubMed ID: 12657309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How do snake curaremimetic toxins discriminate between nicotinic acetylcholine receptor subtypes.
    Servent D; Mourier G; Antil S; Ménez A
    Toxicol Lett; 1998 Dec; 102-103():199-203. PubMed ID: 10022254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.